Login / Signup

A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.

Ensieh Nasli-EsfahaniMaryam Mohammadi-KhanaposhtaniSepideh RezaeiYaghoub SarrafiZeinab SharafiNasser SamadiMohammad Ali FaramarziFatemeh BandarianHaleh HamedifarBagher LarijaniMirhamed HajimiriMohammad Mahdavi
Published in: Archiv der Pharmazie (2019)
A series of new Schiff bases bearing 1,2,3-triazole 12a-o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug acarbose. The kinetic study on the most potent compound 12n showed that this compound acted as a competitive α-glucosidase inhibitor. The docking study revealed that the synthesized compounds interacted with the important residues in the active site of α-glucosidase.
Keyphrases
  • molecular docking
  • molecular dynamics simulations
  • emergency department
  • single cell
  • protein protein
  • electronic health record